Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Parasite Immunol ; 23(11): 575-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11703808

ABSTRACT

Taenia solium paramyosin is an immunodominant antigen in human and porcine cysticercosis that has shown promise as a vaccine candidate against schistosomiasis and some filariasis. There are few studies to identify the immunologically relevant regions of paramyosin. In this work, we characterize the humoral and cellular response of neurocysticercotic patients against T. solium paramyosin. Western blots using different recombinant fragments of T. solium paramyosin, showed that the sera from neurocysticercotic patients were strongly reactive against the carboxyl end region, with poor recognition of the central and amino regions. In contrast, the cellular immune response of patients did not show preferential recognition of any region of paramyosin.


Subject(s)
Epitopes, B-Lymphocyte/immunology , Epitopes, T-Lymphocyte/immunology , Helminth Proteins/immunology , Neurocysticercosis/immunology , Taenia/immunology , Animals , Blotting, Western , Epitope Mapping , Humans , Peptide Fragments/immunology , Recombinant Proteins/immunology
2.
Infect Immun ; 69(9): 5412-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11500411

ABSTRACT

Paramyosin has been proposed as a vaccine candidate in schistosomiasis and filariasis. However, limited information is available about its protective potential against cysticercosis and the immune response it induces. Immunization of mice with recombinant full-length paramyosin of Taenia solium (TPmy) results in about a 52% reduction in parasite burden after a subsequent challenge by intraperitoneal inoculation of Taenia crassiceps cysticerci. Immunization assays using recombinant fragments of TPmy, corresponding approximately to thirds on the amino, central, or carboxyl regions, suggest that protective epitopes are located mostly in the amino-end third. Proliferation assays using T cells obtained from mice immunized with the full-length recombinant TPmy also showed a preferential response to the amino-terminal fragment. In contrast, antibodies in the sera from these mice predominantly recognize epitopes located in the carboxyl-terminal fragment, being the immunoglobulin G1 subclass, the predominant antibody isotype. Characterization of the cellular immune response induced against the protective amino-terminal fragment reveals production of gamma interferon and interleukin-2, but not interleukin-4, suggesting a Th1-like profile.


Subject(s)
Cysticercosis/immunology , Cysticercosis/prevention & control , Taenia/immunology , Tropomyosin/immunology , Vaccines/immunology , Animals , Antibodies, Helminth/blood , Cysticercosis/parasitology , Cytokines/biosynthesis , Disease Models, Animal , Female , Lymphocyte Activation , Mice , Mice, Inbred BALB C , Recombinant Proteins/genetics , Recombinant Proteins/immunology , T-Lymphocytes/immunology , Tropomyosin/genetics , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...